Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Optimising the management of patients with multiple myeloma in Spain: A measurement of the social return on investment
Impacto económico del uso de patiromer en enfermedad renal crónica o insuficiencia cardíaca para el tratamiento de la hiperpotasemia crónica en España
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System
Análisis de las estrategias dirigidas a aumentar la cobertura de vacunación antigripal en personas de 65 años y más
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
